Lillys
-
USA
Lilly’s obesity pill hits nearly 4000 prescriptions in second week after launch
By Sriparna Roy April 24 (Reuters) – Eli Lilly’s newly launched oral weight-loss drug was prescribed 3,707 times in the…
Read More » -
USA
Eli Lilly’s new shot shows solid weight loss in study — plus, a way for Nvidia to perk up
Every weekday, CNBC Investment Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap…
Read More » -
USA
Eli Lilly’s obesity drug retatrutide clears late-stage diabetes trial
The Eli Lilly logo is seen at the company’s office in San Diego, California, USA on November 21, 2025. Mike…
Read More » -
USA
The market likes what it heard from the Fed — plus, Lilly’s new $6B manufacturing investment
Every weekday, CNBC Investment Club with Jim Cramer publishes Homestretch, an actionable afternoon update just in time for the final…
Read More » -
USA
Lilly’s Donanemab Wins India Approval For Alzheimer’s
This article was first published on: GuruFocus. Eli Lilly (NYSE:LLY) I achieved a meaningful international connection India’s drug regulator won…
Read More » -
USA
Eli Lilly’s amylin obesity drug shows up to 20% weight loss in study
The Eli Lilly Biotechnology Center was shown on March 1, 2023 in San Diego, California. Mike Blake | Reuters Eli…
Read More » -
USA
Lilly’s experimental drug shows promise with 20.1% weight loss in mid-stage trial
(Reuters) -Eli Lilly said on Thursday its experimental obesity drug helped patients lose 20.1% of their weight in a mid-stage…
Read More » -
USA
4 reasons to like Wells, Lilly’s latest launch, Boeing ramps production
Every day during the week, Jim Crammer and CNBC Investment Club released Homestretch, a processable afternoon update at the last…
Read More » -
USA
Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug
A sign with the company logo is sitting outside the center of Eli Lilly in Indiana, Indiana, Indiana on 17…
Read More »
